Tag: post-market monitoring

The FDA uses FAERS, Sentinel, and MedWatch to monitor generic drugs after approval, catching rare side effects and manufacturing issues that clinical trials miss. With 90% of prescriptions filled with generics, post-market surveillance is critical for patient safety.